Clinical Trials · NCT02123576

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

Phase
N/A
Recruitment status
Terminated
Sponsor
Patrick Northup, MD
Enrollment
12
Start date
Apr 2014
Locations
1 site, United States
Primary endpoint
Number of Participants With Treatment Success
View Octreotide compound reference